Detalhe da pesquisa
1.
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
Blood
; 128(26): 3083-3100, 2016 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27760757
2.
Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?
Br J Haematol
; 179(3): 488-496, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28832956
3.
Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 22(7): 1333-1337, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27064056
4.
Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells.
Cell Rep Med
; 4(8): 101158, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586321
5.
Clinical characteristics and outcomes of Castleman disease: a multicenter Consortium study of 428 patients with 15-year follow-up.
Am J Cancer Res
; 12(9): 4227-4240, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36225639
6.
Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high-risk follicular lymphoma due to severe haematological and infectious toxicity.
Br J Haematol
; 175(3): 531-533, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26683805
7.
Characteristics and management of rash following lenalidomide and rituximab in patients with untreated indolent non-Hodgkin lymphoma.
Haematologica
; 100(11): e454-7, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26250576
8.
A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma.
Sci Rep
; 9(1): 1322, 2019 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30718585
9.
Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma.
Int J Radiat Oncol Biol Phys
; 100(5): 1146-1154, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29452771
10.
High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
J Clin Oncol
; 23(28): 7013-23, 2005 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16145068
11.
Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy.
JAMA Oncol
; 2(8): 1065-9, 2016 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27227654
12.
Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma.
Leuk Lymphoma
; 61(12): 2985-2989, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32628087
13.
Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.
Int J Radiat Oncol Biol Phys
; 92(1): 113-21, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25863759
14.
Mantle cell lymphoma: non-myeloablative versus dose-intensive therapy.
Leuk Lymphoma
; 44 Suppl 3: S69-75, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-15202528
15.
Gastric mucosa-associated lymphoid tissue lymphoma.
Semin Oncol
; 37(3): 183-7, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20709202
16.
Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma.
Cancer
; 97(3): 586-91, 2003 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12548600